Welcome to our dedicated page for HEXO news (Ticker: HEXO), a resource for investors and traders seeking the latest updates and insights on HEXO stock.
HEXO Corp., formerly known as Hydropothecary, is a leading licensed producer and distributor of medical marijuana under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR). Dedicated to medical excellence, HEXO excels in advanced cultivation techniques, stringent process controls, quality assurance testing, ongoing research and development, and exceptional customer service.
With a focus on expanding its operations, HEXO is set to add a significant 250,000 square feet greenhouse in 2018 to meet growing demand. The company is constantly seeking talented, energetic, and specialized professionals to join its dynamic team and contribute to the rapidly evolving cannabis industry.
HEXO's product portfolio includes a wide range of medical cannabis products designed to meet the diverse needs of patients. The company is committed to innovation and quality, ensuring that all products meet the highest standards of safety and efficacy.
In recent news, HEXO Corp. has announced key partnerships and strategic initiatives aimed at bolstering its market position and expanding its product offerings. These include collaborations with leading organizations and the introduction of new, innovative products that cater to both the medical and recreational cannabis markets.
Financially, HEXO has shown remarkable growth, reflecting its strong market presence and operational efficiency. The company continues to invest in infrastructure and technology to support its long-term growth strategy and maintain its competitive edge in the industry.
For more information on HEXO Corp.'s latest developments, financial performance, and upcoming projects, visit our news section for the most updated data and insights.
HEXO Corp (TSX: HEXO; NYSE: HEXO) announced that its Chief Financial Officer, Trent MacDonald, will host a live 'Ask Me Anything' (AMA) on Reddit on March 24, 2021, at 6:00 p.m. ET. The session, managed by the Cannalysts, aims to provide insights and engage with participants. Attendees can submit questions for the 90-minute event via this link. HEXO Corp is known for its innovative cannabis products serving both the adult-use and medical markets.
HEXO Corp. reported strong financial results for 2Q21, achieving a 94% annual revenue increase to $32.8M and a positive adjusted EBITDA of $202. The company's adult-use revenue rose 10.5% sequentially, marking the fifth consecutive growth quarter. HEXO maintained its number one market position in Quebec, while expanding its presence across Canada. The successful relaunch of the UP Cannabis brand contributed $3.2M in sales. Upcoming acquisition of Zenabis is expected to enhance growth prospects, solidifying HEXO’s position among top Canadian cannabis producers.
HEXO Corp plans to release its fiscal second quarter 2021 financial results on March 18, 2021, before market hours. The Company will also host a webcast for investors at 8:30 a.m. EST to discuss these results. HEXO Corp, a recognized leader in the cannabis consumer packaged goods sector, operates under brands like HEXO Cannabis and Up Cannabis in the Canadian market.
HEXO Corp. and Zenabis Global Inc. have announced a definitive arrangement agreement for HEXO to acquire all of Zenabis’ common shares in an all-share transaction valued at approximately $235 million. Zenabis shareholders will receive 0.01772 HEXO shares per Zenabis share, representing a 19% premium based on the recent average share price. The acquisition aims to position HEXO as a top three licensed producer in Canada, enhance its European market access, and achieve annual synergies of about $20 million. The transaction requires shareholder approval and regulatory clearances.
HEXO Corp has appointed Charles Bowman as General Manager of its US operations effective immediately. His extensive background in commercial growth, particularly in the natural biotechnology sector, is expected to enhance HEXO's presence in the US market. The CEO, Sebastien St-Louis, emphasized the importance of this leadership role as the company looks to expand production facilities in Colorado and strengthen its relationship with Truss CBD USA, a joint venture with Molson Coors. Bowman's experience spans nearly three decades in senior roles at leading ingredient suppliers.
The cannabis industry is projected to reach $40.6 billion in global licensed dispensary sales by 2024, with the US contributing approximately $30 billion. Recreational cannabis sales are expected to hit $26.7 billion and medical cannabis $13.9 billion. A focus on cannabis delivery services is emerging as a key growth area. NxGen Brands has acquired an exclusive license for tracking technologies to enhance its cannabis delivery app. Additionally, Sundial Growers launched new premium cannabis derivatives, while HEXO Corp's joint venture Truss CBD USA introduced a sparkling CBD beverage line in Colorado.
HEXO Corp has announced the successful registration of its trademark, Powered by HEXO, with the European Union Intellectual Property Office after a two-year process. This milestone supports HEXO's strategy and enhances its brand's global value. CEO Sebastien St-Louis highlighted that this trademark will support current joint-venture partners and attract potential non-beverage CPG partners. The initiative integrates research, regulatory expertise, and consumer understanding, contributing to the quality of award-winning products.
HEXO Corp has appointed Rose Marie Gage to its Board of Directors, increasing the board to seven members. Gage brings over 30 years of experience from multinational firms like Westinghouse and GE, focusing on business development, strategy, and governance. Dr. Michael Munzar, Chair of the Board, highlighted her operational effectiveness as crucial for HEXO's goals to achieve EPS positivity, expand market share in Canada, and grow U.S. operations. Gage holds significant qualifications, including a Chartered Director designation and certifications in Lean Six Sigma and Cyber-Security.
HEXO Corp and Molson Coors Beverage Company announced the U.S. launch of VeryvellTM, a non-alcoholic sparkling CBD beverage line available exclusively in Colorado. The product is offered in three flavors: Focus, Mind & Body, and Unwind. This launch follows the success of Truss Beverage Brands in Canada, with plans for further investment in U.S. operations to expand their market presence. VeryvellTM adheres to Colorado's regulatory standards for hemp-derived CBD. This collaboration aims to establish Truss CBD USA as a key player in the growing CBD beverage market.
HEXO Corp (TSX: HEXO; NYSE: HEXO) announced that its CEO, Sebastien St-Louis, will join a panel on January 14, 2021, at 8:00 am EST. The discussion will focus on growth opportunities for Canadian licensed producers in the United States and is moderated by David Kideckel of ATB Capital Markets. Media representatives can access the broadcast by contacting Brenda Hanchar at AltaCorp Capital. HEXO is recognized for its cannabis consumer products and operates under various brands in both the adult-use and medical markets.
FAQ
What is the market cap of HEXO (HEXO)?
What does HEXO Corp. do?
What recent expansion projects has HEXO undertaken?
What kind of products does HEXO offer?
Has HEXO announced any new partnerships?
What is HEXO's financial outlook?
Where can I find more information about HEXO's latest news?
What regulatory framework does HEXO operate under?
Is HEXO involved in research and development?
What is HEXO's commitment to quality?
How does HEXO contribute to the cannabis industry?
